Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    16549646 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities
Condition: Peripheral Arterial Disease
Interventions: Procedure: Endovascular revascularization;   Drug: 1 month daily 75 mg plavix;   Drug: 12 months daily 75 mg plavix;   Drug: 12 months daily 75-100 mg aspirin;   Drug: 1 month daily 75-100 mg aspirin
2 Recruiting Intensive Rehabilitation in Peripheral Arterial Disease With Claudication: Effects of a Treadmill Training With Active Recovery
Conditions: Peripheral Arterial Disease;   Claudication
Interventions: Procedure: experimental rehabilitation program;   Procedure: conventional rehabilitation program
3 Recruiting Patients With Intermittent Claudication Injected With ALDH Bright Cells
Conditions: Peripheral Artery Disease;   Intermittent Claudication
Interventions: Biological: ALD-301;   Biological: Placebo (vehicle)
4 Recruiting Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities (ASPIRE PAD)
Condition: Peripheral Arterial Disease, Antiplatelet Therapy
Interventions: Drug: ASA (75-100 mg) + clopidogrel 75 mg: 12m treatment intervention;   Drug: ASA (75-100 mg) + clopidogrel: 1m (control arm)

Indicates status has not been verified in more than two years